Sign up
Pharma Capital
EPIC: SPH
Market: LSE
52-week High/Low: 36.35p / 21.00p
Sector: Pharma & Biotech
Market Cap: 116.62M

Sinclair Pharma plc is an international company operating in the fast growth, high gross margin, global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. The...

Sinclair Pharma

www.sinclairpharma.com

Interactive graph

col 3
col 4
col 5
col 6
View full SPH profile View Profile
View All

Market Reports Including SPH

VIEW ALL

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.